vs
Side-by-side financial comparison of Dover Corporation (DOV) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
Dover Corporation is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× SELECT MEDICAL HOLDINGS CORP). Dover Corporation runs the higher net margin — 13.4% vs 1.4%, a 12.0% gap on every dollar of revenue. On growth, Dover Corporation posted the faster year-over-year revenue change (12.5% vs 6.4%). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -1.8%).
Dover Corporation is an American conglomerate manufacturer of industrial products. The Downers Grove, Illinois-based company was founded in 1955. As of 2021, Dover's business was divided into five segments: Engineered Products, Clean Energy and Fueling, Imaging & Identification, Pumps & Process Solutions and Climate and Sustainability Technologies. Dover is a constituent of the S&P 500 index and trades on the New York Stock Exchange under the symbol DOV. Dover was ranked 448 in the 2024 Fortu...
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
DOV vs SEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.1B | $1.4B |
| Net Profit | $282.1M | $20.2M |
| Gross Margin | 39.1% | — |
| Operating Margin | 16.5% | 4.6% |
| Net Margin | 13.4% | 1.4% |
| Revenue YoY | 12.5% | 6.4% |
| Net Profit YoY | 22.2% | 225.7% |
| EPS (diluted) | $2.06 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.4B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $2.0B | $1.3B | ||
| Q2 24 | $2.2B | $1.3B |
| Q1 26 | $282.1M | — | ||
| Q4 25 | $282.1M | $20.2M | ||
| Q3 25 | $302.0M | $28.8M | ||
| Q2 25 | $279.1M | $40.6M | ||
| Q1 25 | $230.8M | $56.7M | ||
| Q4 24 | $1.4B | $-16.1M | ||
| Q3 24 | $347.1M | $55.6M | ||
| Q2 24 | $281.8M | $77.6M |
| Q1 26 | 39.1% | — | ||
| Q4 25 | 39.1% | — | ||
| Q3 25 | 40.1% | — | ||
| Q2 25 | 39.9% | — | ||
| Q1 25 | 40.0% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 37.7% | — |
| Q1 26 | 16.5% | — | ||
| Q4 25 | 16.5% | 4.6% | ||
| Q3 25 | 18.2% | 5.4% | ||
| Q2 25 | 17.3% | 6.5% | ||
| Q1 25 | 15.9% | 8.3% | ||
| Q4 24 | 14.0% | 1.6% | ||
| Q3 24 | 16.8% | 4.3% | ||
| Q2 24 | 17.0% | 5.8% |
| Q1 26 | 13.4% | — | ||
| Q4 25 | 13.4% | 1.4% | ||
| Q3 25 | 14.5% | 2.1% | ||
| Q2 25 | 13.6% | 3.0% | ||
| Q1 25 | 12.4% | 4.2% | ||
| Q4 24 | 96.4% | -1.2% | ||
| Q3 24 | 17.5% | 4.4% | ||
| Q2 24 | 12.9% | 6.1% |
| Q1 26 | $2.06 | — | ||
| Q4 25 | $2.06 | $0.17 | ||
| Q3 25 | $2.19 | $0.23 | ||
| Q2 25 | $2.02 | $0.32 | ||
| Q1 25 | $1.67 | $0.44 | ||
| Q4 24 | $10.38 | $-0.12 | ||
| Q3 24 | $2.51 | $0.43 | ||
| Q2 24 | $2.04 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $26.5M |
| Total DebtLower is stronger | $3.3B | $1.8B |
| Stockholders' EquityBook value | $7.4B | $1.7B |
| Total Assets | $13.4B | $5.9B |
| Debt / EquityLower = less leverage | 0.45× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M |
| Q1 26 | $3.3B | — | ||
| Q4 25 | $3.3B | $1.8B | ||
| Q3 25 | $3.1B | $1.7B | ||
| Q2 25 | $3.1B | $1.8B | ||
| Q1 25 | $3.0B | $1.8B | ||
| Q4 24 | $2.9B | $1.7B | ||
| Q3 24 | $3.0B | $3.1B | ||
| Q2 24 | $3.0B | $3.6B |
| Q1 26 | $7.4B | — | ||
| Q4 25 | $7.4B | $1.7B | ||
| Q3 25 | $7.7B | $1.7B | ||
| Q2 25 | $7.4B | $1.7B | ||
| Q1 25 | $7.1B | $1.7B | ||
| Q4 24 | $7.0B | $1.7B | ||
| Q3 24 | $5.7B | $1.9B | ||
| Q2 24 | $5.4B | $1.4B |
| Q1 26 | $13.4B | — | ||
| Q4 25 | $13.4B | $5.9B | ||
| Q3 25 | $13.4B | $5.7B | ||
| Q2 25 | $13.2B | $5.7B | ||
| Q1 25 | $12.6B | $5.7B | ||
| Q4 24 | $12.5B | $5.6B | ||
| Q3 24 | $11.9B | $8.0B | ||
| Q2 24 | $11.3B | $7.9B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.45× | 1.06× | ||
| Q3 25 | 0.40× | 1.03× | ||
| Q2 25 | 0.41× | 1.10× | ||
| Q1 25 | 0.42× | 1.03× | ||
| Q4 24 | 0.42× | 1.01× | ||
| Q3 24 | 0.53× | 1.62× | ||
| Q2 24 | 0.55× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $64.3M |
| Free Cash FlowOCF − Capex | — | $5.2M |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.9M | $64.3M | ||
| Q3 25 | $424.2M | $175.3M | ||
| Q2 25 | $212.3M | $110.3M | ||
| Q1 25 | $157.5M | $-3.5M | ||
| Q4 24 | $439.0M | $125.4M | ||
| Q3 24 | $353.2M | $181.0M | ||
| Q2 24 | $203.7M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $487.0M | $5.2M | ||
| Q3 25 | $370.1M | $122.2M | ||
| Q2 25 | $151.4M | $45.6M | ||
| Q1 25 | $109.3M | $-55.8M | ||
| Q4 24 | $385.0M | $62.0M | ||
| Q3 24 | $325.0M | $130.3M | ||
| Q2 24 | $162.8M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 23.2% | 0.4% | ||
| Q3 25 | 17.8% | 9.0% | ||
| Q2 25 | 7.4% | 3.4% | ||
| Q1 25 | 5.9% | -4.1% | ||
| Q4 24 | 25.8% | 4.7% | ||
| Q3 24 | 16.4% | 10.2% | ||
| Q2 24 | 7.5% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 4.2% | ||
| Q3 25 | 2.6% | 3.9% | ||
| Q2 25 | 3.0% | 4.8% | ||
| Q1 25 | 2.6% | 3.9% | ||
| Q4 24 | 3.6% | 4.8% | ||
| Q3 24 | 1.4% | 4.0% | ||
| Q2 24 | 1.9% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.93× | 3.19× | ||
| Q3 25 | 1.40× | 6.09× | ||
| Q2 25 | 0.76× | 2.72× | ||
| Q1 25 | 0.68× | -0.06× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.02× | 3.25× | ||
| Q2 24 | 0.72× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOV
Segment breakdown not available.
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
